PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks

Insights into ASX Stocks

Nanoveu (ASX: NVU)

Nanoveu (ASX: NVU): 16nm Silicon Arrives as Design Wins Become the Next Test

Nov 3, 2026
Proactive Equities Team

Nanoveu (ASX: NVU) has received its first 16nm ECS-DoT chip samples from TSMC and grown its edge-AI customer pipeline to 33 opportunities, but a first design win and funding from options remain the key tests ahead.

Canterbury Resources (ASX: CBY)

Canterbury Resources (ASX: CBY): Briggs PFS Progresses as John Hill Drilling and Funding Plans Move Ahead

Nov 3, 2026
Proactive Equities Team

Canterbury Resources (ASX: CBY) is advancing its Briggs Project through an ongoing PFS while progressing John Hill drilling at Monto, securing additional funding through a share placement and a proposed A$1 million Share Purchase Plan.

Power Minerals (ASX: PNN)

Power Minerals (ASX: PNN): Nasdaq-Listed CRML Commits A$5M to Brazilian Minerals Projects

Nov 3, 2026
Proactive Equities Team

Power Minerals (ASX: PNN) has secured a A$5 million strategic investment from Nasdaq-listed Critical Metals Corp to advance its Brazilian rare earth projects, expand exploration activities and support future technical studies.

Dateline Resources (ASX: DTR)

Dateline Resources (ASX: DTR): Mojave Injunction Fight Heads to Ninth Circuit

Nov 3, 2026
Proactive Equities Team

Dateline Resources (ASX: DTR) shares jumped over 10% after a US judge denied stay requests on the Mojave injunction, sending the fight to the Ninth Circuit, while the managing director also bought more shares on market.

Turnstone Resources (ASX: TSR)

Turnstone Resources (ASX: TSR): Strategic Shift to Critical Minerals Puts Swedish Exploration in Focus

Nov 3, 2026
Proactive Equities Team

Turnstone Resources (ASX: TSR) has shifted its focus towards critical minerals exploration in Sweden, completed airborne magnetic surveys across three projects and secured additional funding while reviewing its German potash portfolio.

Neurizon Therapeutics (ASX: NUZ)

Neurizon Therapeutics (ASX: NUZ): A$6.3M Raise Clears Path to ALS Trial Readout

Nov 2, 2026
Proactive Equities Team

Neurizon Therapeutics (ASX: NUZ) has secured A$4.3 million from a placement, launched a share purchase plan and redeemed all remaining Obsidian convertible notes, aiming to stay funded through the HEALEY ALS Platform Trial readout in 2027.

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

12345...88
Page 3 of 88